ATE303135T1 - Pharmazeutische formulierungen zur gesteuerten freisetzung von 4-amino-6,7-dimethoxy-2-(5- - Google Patents

Pharmazeutische formulierungen zur gesteuerten freisetzung von 4-amino-6,7-dimethoxy-2-(5-

Info

Publication number: ATE303135T1
Authority: AT; Austria
Prior art keywords: dimethoxy; amino; controlled release; pharmaceutical formulations; formulations
Prior art date: 2001-10-11

Application number

AT02775048T

Other languages

English (en)

Inventor

John D Davis

Michael J Humphrey

Ross J Macrae

Janet S Smith

Original Assignee

Pfizer Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-11

Filing date

2002-09-30

Publication date

2005-09-15

2002-09-30 Application filed by Pfizer Ltd filed Critical Pfizer Ltd

2005-09-15 Application granted granted Critical

2005-09-15 Publication of ATE303135T1 publication Critical patent/ATE303135T1/de

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate

AT02775048T 2001-10-11 2002-09-30 Pharmazeutische formulierungen zur gesteuerten freisetzung von 4-amino-6,7-dimethoxy-2-(5- ATE303135T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0124455.7A GB0124455D0 (en)	2001-10-11	2001-10-11	Pharmaceutical formulations
PCT/IB2002/004040 WO2003032956A1 (en)	2001-10-11	2002-09-30	Pharmaceutical formulations for the controlled release of 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl) quinazoline

Publications (1)

Publication Number	Publication Date
ATE303135T1 true ATE303135T1 (de)	2005-09-15

Family

ID=9923660

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02775048T ATE303135T1 (de)	2001-10-11	2002-09-30	Pharmazeutische formulierungen zur gesteuerten freisetzung von 4-amino-6,7-dimethoxy-2-(5-

Country Status (32)

Country	Link
EP (1)	EP1434570B8 (de)
JP (1)	JP4131471B2 (de)
KR (1)	KR20050032510A (de)
CN (1)	CN1568180A (de)
AP (1)	AP2004003001A0 (de)
AR (1)	AR036782A1 (de)
AT (1)	ATE303135T1 (de)
BR (1)	BR0213196A (de)
CA (1)	CA2461168A1 (de)
CO (1)	CO5560534A2 (de)
DE (1)	DE60205925T2 (de)
DK (1)	DK1434570T3 (de)
DO (1)	DOP2002000464A (de)
EA (1)	EA006168B1 (de)
ES (1)	ES2246017T3 (de)
GB (1)	GB0124455D0 (de)
GT (1)	GT200200184A (de)
HR (1)	HRP20040261A2 (de)
HU (1)	HUP0600064A3 (de)
IL (1)	IL160969A0 (de)
IS (1)	IS7179A (de)
MA (1)	MA27075A1 (de)
MX (1)	MXPA04003293A (de)
NO (1)	NO20041520L (de)
OA (1)	OA12709A (de)
PA (1)	PA8556001A1 (de)
PE (1)	PE20030551A1 (de)
PL (1)	PL369666A1 (de)
SV (1)	SV2004001279A (de)
UY (1)	UY27477A1 (de)
WO (1)	WO2003032956A1 (de)
ZA (1)	ZA200401976B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0317663D0 (en) *	2003-07-29	2003-09-03	Astrazeneca Ab	Pharmaceutical composition
RU2663663C2 (ru)	2013-03-14	2018-08-08	Эмджен Инк.	Соль омекамтива мекарбила и способ ее получения
KR101943592B1 (ko)	2017-08-31	2019-01-30	조현우	데이터 마이닝 기법을 이용한 전자가계부 시스템

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2053120T3 (es) *	1990-07-02	1994-07-16	Bend Res Inc	Perlas microporosas asimetricas para liberacion controlada.
FR2752737B1 (fr) *	1996-08-29	1998-10-02	Synthelabo	Comprime a liberation controlee de chlorhydrate d'alfuzosine
GB9700504D0 (en) *	1997-01-11	1997-02-26	Pfizer Ltd	Pharmaceutical compounds
IL141235A (en) *	2000-02-09	2012-04-30	Novartis Int Pharm Ltd	Combined use of an alpha-adrenoceptor antagonist and a muscarinic antagonist in the preparation of a drug for the treatment of non-malignant prostatic hyperplasia
HUP0300006A3 (en) *	2000-03-03	2006-01-30	Pfizer	4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylat and polymorphs, process for their preparation and pharmaceutical compositions containing them

2001
- 2001-10-11 GB GBGB0124455.7A patent/GB0124455D0/en not_active Ceased
2002
- 2002-09-12 DO DO2002000464A patent/DOP2002000464A/es unknown
- 2002-09-17 GT GT200200184A patent/GT200200184A/es unknown
- 2002-09-30 PL PL02369666A patent/PL369666A1/xx not_active Application Discontinuation
- 2002-09-30 EP EP02775048A patent/EP1434570B8/de not_active Expired - Lifetime
- 2002-09-30 ES ES02775048T patent/ES2246017T3/es not_active Expired - Lifetime
- 2002-09-30 HU HU0600064A patent/HUP0600064A3/hu unknown
- 2002-09-30 CN CNA02820042XA patent/CN1568180A/zh active Pending
- 2002-09-30 IL IL16096902A patent/IL160969A0/xx unknown
- 2002-09-30 OA OA1200400094A patent/OA12709A/en unknown
- 2002-09-30 WO PCT/IB2002/004040 patent/WO2003032956A1/en active IP Right Grant
- 2002-09-30 JP JP2003535760A patent/JP4131471B2/ja not_active Expired - Fee Related
- 2002-09-30 AT AT02775048T patent/ATE303135T1/de not_active IP Right Cessation
- 2002-09-30 MX MXPA04003293A patent/MXPA04003293A/es active IP Right Grant
- 2002-09-30 BR BR0213196-0A patent/BR0213196A/pt not_active IP Right Cessation
- 2002-09-30 CA CA002461168A patent/CA2461168A1/en not_active Abandoned
- 2002-09-30 DE DE60205925T patent/DE60205925T2/de not_active Expired - Lifetime
- 2002-09-30 DK DK02775048T patent/DK1434570T3/da active
- 2002-09-30 EA EA200400431A patent/EA006168B1/ru not_active IP Right Cessation
- 2002-09-30 AP APAP/P/2004/003001A patent/AP2004003001A0/en unknown
- 2002-09-30 KR KR1020047005316A patent/KR20050032510A/ko not_active Application Discontinuation
- 2002-10-09 AR ARP020103805A patent/AR036782A1/es unknown
- 2002-10-09 PE PE2002000996A patent/PE20030551A1/es not_active Application Discontinuation
- 2002-10-09 UY UY27477A patent/UY27477A1/es not_active Application Discontinuation
- 2002-10-10 SV SV2002001279A patent/SV2004001279A/es not_active Application Discontinuation
- 2002-10-10 PA PA20028556001A patent/PA8556001A1/es unknown
2004
- 2004-03-11 IS IS7179A patent/IS7179A/is unknown
- 2004-03-11 ZA ZA200401976A patent/ZA200401976B/en unknown
- 2004-03-17 HR HR20040261A patent/HRP20040261A2/hr not_active Application Discontinuation
- 2004-03-18 CO CO04025929A patent/CO5560534A2/es not_active Application Discontinuation
- 2004-04-05 NO NO20041520A patent/NO20041520L/no unknown
- 2004-04-08 MA MA27623A patent/MA27075A1/fr unknown

Also Published As

Publication number	Publication date
DK1434570T3 (da)	2005-11-07
DE60205925D1 (de)	2005-10-06
UY27477A1 (es)	2003-05-30
JP4131471B2 (ja)	2008-08-13
DOP2002000464A (es)	2003-04-15
EP1434570B1 (de)	2005-08-31
BR0213196A (pt)	2004-08-31
EP1434570B8 (de)	2005-10-26
SV2004001279A (es)	2004-02-19
GB0124455D0 (en)	2001-12-05
ES2246017T3 (es)	2006-02-01
NO20041520L (no)	2004-04-05
DE60205925T2 (de)	2006-06-08
EP1434570A1 (de)	2004-07-07
HUP0600064A2 (en)	2006-06-28
WO2003032956A1 (en)	2003-04-24
IL160969A0 (en)	2004-08-31
AP2004003001A0 (en)	2004-03-31
OA12709A (en)	2006-06-26
PA8556001A1 (es)	2003-07-28
MXPA04003293A (es)	2004-07-23
PL369666A1 (en)	2005-05-02
ZA200401976B (en)	2004-07-12
HRP20040261A2 (en)	2004-08-31
CA2461168A1 (en)	2003-04-24
PE20030551A1 (es)	2003-06-26
EA006168B1 (ru)	2005-10-27
MA27075A1 (fr)	2004-12-20
IS7179A (is)	2004-03-11
KR20050032510A (ko)	2005-04-07
HUP0600064A3 (en)	2007-02-28
CN1568180A (zh)	2005-01-19
EA200400431A1 (ru)	2004-08-26
CO5560534A2 (es)	2005-09-30
AR036782A1 (es)	2004-10-06
GT200200184A (es)	2003-05-23
JP2005507909A (ja)	2005-03-24

Legal Events

Date

Code

Title

Description

2006-03-15

UEP

Publication of translation of european patent specification

Ref document number: 1434570

Country of ref document: EP

2007-06-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE60220661D1 (de)	2007-07-26	Transdermales pflaster zur verabreichung von fentanyl
DK1345910T3 (da)	2009-07-20	Quinazolinderivater, lægemidler indeholdende forbindelserne, deres anvendelse og fremgangsmåde til fremstilling deraf
NO20033556L (no)	2003-10-09	Farmasöytiske formuleringer
DK1292594T3 (da)	2004-12-06	Quinazolinderivater til behandling af tumorer
DE60232251D1 (de)	2009-06-18	Pharmazeutische zusammensetzungen zur behandlung von asthma
FI20011478A0 (fi)	2001-07-05	Farmaseuttinen koostumus
DE50206657D1 (de)	2006-06-08	Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
IS7691A (is)	2005-02-09	Lyfjasamsetningar til að meðhöndla æxli
DE60206889D1 (de)	2005-12-01	Pharmazeutische formulierung enthaltend bicalutamid
ATE334656T1 (de)	2006-08-15	Flüssige pharmazeutische zusammensetzung
DE60118859D1 (de)	2006-05-24	Pharmazeutische Zusammensetzung enthaltend Trehalose zur ophthalmischen Verwendung
DE60126838D1 (de)	2007-04-05	Amidoacetonitrile zur Bekämpfung von Endoparasiten
DE60211183D1 (de)	2006-06-08	Pharmazeutische zusammensetzung enthaltend lumiracoxib
FI20022128A (fi)	2003-06-06	Farmaseuttinen koostumus
DE60225154D1 (de)	2008-04-03	Neues selbstemulgierendes arzneimittelfreisetzungssystem
DE60217390D1 (de)	2007-02-15	Bicalutamid enthaltende pharmazeutische zusammensetzung
DK1475379T3 (da)	2007-09-03	Anvendelse af scopinesterderivater til fremstilling af lægemidler
ATE303135T1 (de)	2005-09-15	Pharmazeutische formulierungen zur gesteuerten freisetzung von 4-amino-6,7-dimethoxy-2-(5-
DE10291905D2 (de)	2004-05-27	Pharmazeutische Zusammensetzung
DE60227896D1 (de)	2008-09-11	Verfahen zur Herstellung von Polyalkylphenoxyaminoalkanen
ATE350029T1 (de)	2007-01-15	Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
DK1385512T3 (da)	2006-05-22	Anvendelse af pyridoindolonderivater til fremstilling af anticancerlægemidler
DE10107261B4 (de)	2005-03-10	Pharmazeutische Zusammensetzung
EE200300563A (et)	2004-02-16	Bensüülaminopürimidiiniühendid, nende kasutamine ja ravim
IT1338456B1 (it)	2007-03-12	Procedimento per la preparazione di alchiluree da o ,d-dimetil ditiocarbonato